Stoltmann Law Offices continues to investigate Morgan Stanley and its sales of Cushing MLP High Income Exchange Traded Notes. A claim was recently filed with the Financial Industry Regulatory Authority (FINRA) on behalf of two North Carolina investors who alleged claims for violation of common law fraud, breach of fiduciary duty, negligence and negligent supervision. Morgan Stanley allegedly recommended its proprietary Cushing MLP High Income exchange-traded notes (ETNs) to its clients and failed to adequately disclose the risks of the those investments to the clients. ETNs are typically risky and illiquid investments that are not suitable for every client. A broker must take into account a client’s net worth, age and investment objectives among other factors, or the investment firm can be held liable for investment losses incurred. The Cushing MLP ETN declined more than 65% in value as recently as October 2014.
The posting on this site are mere OPINIONS and NOT statements of fact in any way whatsoever. The information should not be relied upon and there have been no findings made against the firms or individuals referenced on this site. In addition, this Blog is made available for educational purposes only and incorporates information from the web as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this blog site you understand that there is no attorney client relationship between you and Stoltmann Law Offices (161 N Clark Street 16th Floor Chicago, IL 60601). The Blog opinions should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.
PLEASE NOTE THIS IS ADVERTISING AND IT IS NOT A NEWSPAPER ARTICLE OR POST FROM AN INDEPENDENT OR NON-BIASED, NEWS SITE, NEWS SOURCE OR NEWSPAPER.